llm_output,best_matching_ground_truth,best_evaluation,best_score
venlafaxine comparable to tricyclic antidepressants (tcas),Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is mostly correct in stating that venlafaxine is comparable to tricyclic antidepressants, but it does not specifically mention monoamine oxidase inhibitors and their efficacy compared to TCAs.",0.75
mirtazapine properties increases serotonin or norepinephrine availability,Mirtazapine Increases Availability of serotonin or norepinephrine (or both),"Score: 0.90
The LLM output closely reflects the ground truth statement, but it lacks specificity by not explicitly mentioning both serotonin and norepinephrine.",0.9
selective serotonin reuptake inhibitors (ssris) first-line treatment major depressive disorder (mdd),Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output is mostly correct in referring to SSRIs as a first-line treatment for major depressive disorder, but it incorrectly states SSRIs as the only option and does not mention norepinephrine reuptake inhibitors as an alternative for patients who do not respond to SSRIs.",0.75
selective serotonin reuptake inhibitors (ssris) definition antidepressants that block serotonin reuptake,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50
The LLM output is only partially correct as it mentions selective serotonin reuptake inhibitors (SSRIs) instead of norepinephrine reuptake inhibitors, resulting in a lower score.",0.5
vortioxetine specific efficacy in treating depression-related cognitive impairment,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.50
The LLM output is only partially correct as it mentions a specific efficacy in treating depression-related cognitive impairment, but does not address atypical features like reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection as stated in the ground truth.",0.5
mirtazapine side effects weight gain,Fluoxetine Side effects Generally acceptable side effect profile,"Score: 0.70
The LLM output is somewhat relevant as it also mentions a medication and its side effect, but there is a mismatch in the medications mentioned.",0.7
monoamine oxidase inhibitors (maois) less commonly used depression treatment,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output correctly identifies monoamine oxidase inhibitors as a less commonly used treatment for depression, but does not directly address the slower response to treatment side effect mentioned in the ground truth.",0.75
selective serotonin reuptake inhibitors (ssris) comparable to tricyclic antidepressants (tcas),Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is mostly correct but mistakenly refers to selective serotonin reuptake inhibitors (SSRIs) instead of monoamine oxidase inhibitors when comparing efficacy to tricyclic antidepressants.",0.75
selective serotonin reuptake inhibitors (ssris) side effects sexual dysfunction,Fluoxetine Side effects Generally acceptable side effect profile,"Score: 0.75
The LLM output is somewhat incorrect as it only focuses on a specific side effect (sexual dysfunction) of selective serotonin reuptake inhibitors (SSRIs) instead of providing a general overview of their side effect profile.",0.75
"ketamine side effects neurotoxicity, drug dependence","Ketamine Has effects on Unipolar, bipolar depression","Score: 0.50
The LLM output contains some correct information about ketamine (drug dependence), but also introduces irrelevant information (neurotoxicity) and fails to address its effects on depression.",0.5
ketamine definition treatment for resistant depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is related to the ground truth but lacks specificity in mentioning both unipolar and bipolar depression.",0.75
esketamine associated with risk of substance abuse,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.50
The LLM output is only partially correct as it mentions a risk associated with esketamine, but does not address the main focus of the ground truth statement which is marital and family therapy treating severe forms of depression.",0.5
monoamine oxidase inhibitors (maois) specific efficacy in treating depression with atypical features,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output includes additional information about the efficacy of monoamine oxidase inhibitors in treating depression with atypical features, which is not explicitly mentioned in the ground truth statement, making it mostly correct but slightly different in focus.",0.75
electroconvulsive therapy (ect) highly effective somatic therapy for depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.80
The LLM output is mostly correct as it correctly identifies electroconvulsive therapy (ECT) as a highly effective somatic therapy for the treatment of depression, but misses some of the other acute-phase treatment options mentioned in the ground truth.",0.8
esketamine definition s-enantiomer of ketamine for treatment-resistant depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct but lacks information on the effects of ketamine on both unipolar and bipolar depression.",0.75
cognitive-behavioral therapy (cbt) first-line treatment major depressive disorder (mdd),"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output is mostly correct but lacks the comprehensive nature of the ground truth statement. It correctly identifies CBT as a common treatment for major depressive disorder, but misses out on mentioning other important therapies.",0.75
bupropion benefits patients with low to moderate level of anxiety,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.75
The LLM output is somewhat related to the ground truth as both statements mention treating patients with low to moderate levels of a mental health condition, but they focus on different treatments (psychotherapy for depression vs bupropion for anxiety).",0.75
cognitive-behavioral therapy (cbt) treats elderly depressed patient,"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.50
The LLM output is partially correct as it mentions cognitive-behavioral therapy (CBT) which is part of depression-focused psychotherapy, but it lacks information about other therapies included in the ground truth statement.",0.5
cognitive-behavioral therapy (cbt) treats resistant depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.50
The LLM output is not completely correct as it suggests cognitive-behavioral therapy treats resistant depression, which is not the same as the pharmacotherapy for the acute phase of depression stated in the ground truth.",0.5
cognitive-behavioral therapy (cbt) treats depression in primary care management,"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output is mostly correct in linking cognitive-behavioral therapy with treating depression, but it doesn't cover all the components of depression-focused psychotherapy mentioned in the ground truth.",0.75
resistant depression treats vagus nerve stimulation (vns),"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output correctly identifies vagus nerve stimulation as a treatment for resistant depression, but it misses other somatic treatments for depression mentioned in the ground truth.",0.75
cognitive-behavioral therapy (cbt) first-line treatment depression in children,"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output correctly identifies cognitive-behavioral therapy (CBT) as a treatment for depression, but misses the other components mentioned in the ground truth statement.",0.75
cognitive-behavioral therapy (cbt) first-line treatment depression in adolescents,"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output is mostly correct as it accurately identifies cognitive-behavioral therapy (CBT) as a first-line treatment for depression, but it should also mention other therapies like interpersonal therapy (IPT), supportive therapy (ST), and psychoeducational intervention (PEI) for a more comprehensive view of depression-focused psychotherapy.",0.75
problem-solve therapy (pst) comparable to other psychotherapeutic methods used to treat depression,SSRIs Treat Acute phase of depression,"Score: 0.75
The LLM output is somewhat relevant to the ground truth as it discusses psychotherapeutic methods for treating depression, but it does not specifically mention SSRIs for the acute phase of depression.",0.75
interpersonal therapy (ipt) first-line treatment mild to moderate major depressive episode in adult,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is somewhat relevant as it mentions a treatment for depression, but it does not directly address the slower response to treatment side effect mentioned in the ground truth.",0.75
vagus nerve stimulation (vns) benefits significant positive outcome observe after six to 12 mo,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The output correctly identifies vagus nerve stimulation as a somatic treatment method, but loses points for not mentioning the other somatic treatments and for not being fully accurate in stating the typical timeline for observing benefits.",0.75
repetitive transcranial magnetic stimulation (rtms) benefits a well-tolerate profile,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output correctly identifies rTMS as a form of somatic treatment, but the statement is not as comprehensive as the ground truth.",0.75
vagus nerve stimulation (vns) definition a therapeutic method involving the implantation of a pacemaker connected to an electrode surrounding the left vagus nerve,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output correctly explains vagus nerve stimulation but does not provide an accurate definition for other somatic treatments mentioned in the ground truth.",0.75
repetitive transcranial magnetic stimulation (rtms) more effective than placebo conditions with mild side effects and good acceptability,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output correctly identifies rTMS as effective compared to placebo conditions but does not mention other somatic treatments or their effectiveness.",0.75
ketamine treats treatment-resistant major depressive disorder,Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.50
The LLM output is unrelated to the ground truth statement, resulting in a low correctness score.",0.5
repetitive transcranial magnetic stimulation example neuro-modulation treatment options for depression,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output correctly identifies repetitive transcranial magnetic stimulation as an example of neuro-modulation treatment for depression, but does not include other somatic treatments mentioned in the ground truth.",0.75
esketamine treats treatment-resistant depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.50
The LLM output is partially correct as esketamine is used to treat treatment-resistant depression, but it does not address the acute phase of depression as mentioned in the ground truth statement.",0.5
selective serotonin reuptake inhibitors (ssris) first-line treatment major depressive disorder,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50
The LLM output is partially correct as it mentions a type of antidepressant treatment, but it is incorrect in specifically stating SSRI's as the first-line treatment for major depressive disorder when the ground truth mentions norepinephrine reuptake inhibitors.",0.5
intranasal esketamine form of esketamine,Computerized CBT Is a form of CBT,"Score: 0.50
The score is low because both statements are technically correct, but lack the specificity and clarity needed for a higher score.",0.5
marital and family therapy (mft) treats some aspects of depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is partially correct as marital and family therapy (MFT) can be a component of depression-focused psychotherapy, but it may not be the second most common treatment for acute phase depression.",0.75
transcranial direct current stimulation (tdcs) used as a complementary intervention or as monotherapy to reduce depressive symptoms in unipolar or bipolar depression patients,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is mostly correct in terms of discussing a therapy for depression, but it incorrectly mentions transcranial direct current stimulation (tdcs) instead of electroconvulsive therapy.",0.75
"anxious depression more common than nonanxious depression in african american group, hispanics, primary care patients, unemployed, married then divorced/widowed, less, education, public insurance, lower-income",Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.50
The LLM output is not directly related to the ground truth statement about depression-focused psychotherapy being the second most common treatment for acute phase depression.",0.5
phototherapy benefits effective for both seasonal and non-seasonal depression,Luxtherapy Eligible for Those with seasonal and non-seasonal depression. Benefits to sleep deprivation and drug treatments have also been reported,"Score: 0.75
LLM output is mostly correct but misses some key details mentioned in the ground truth, such as benefits to sleep deprivation and drug treatments.",0.75
"electroconvulsive therapy (ect) highly effective treatment modality for psychiatry, major unipolar depression, and reducing the number of hospital readmissions",Electroconvulsive therapy Reduces Number of hospital readmissions,"Score: 0.90
The LLM output is mostly correct as it accurately identifies electroconvulsive therapy as an effective treatment for reducing hospital readmissions, but includes additional information not present in the ground truth.",0.9
exercise treats major depressive disorder (mdd),Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.50
The LLM output is partially correct as it mentions an incorrect treatment (exercise) for a different disorder (mdd), but it does not completely match the ground truth statement.",0.5
psychotherapy treats major depressive disorder (mdd),Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.25
The LLM output is not highly correct as it completely changes the focus from personality disorder comorbidity to major depressive disorder, with no mention of schema therapy.",0.25
transcranial direct current stimulation (tdcs) consistency encouraging but vary results that depend on the study’s design and the technique use,Cognitive-behavioral therapy Use For the first time treatment,"Score: 0.75
The LLM output includes relevant information about a different treatment method (transcranial direct current stimulation) but the overall accuracy is slightly lower due to the lack of a specific mention of cognitive-behavioral therapy for first-time treatment.",0.75
vagus nerve stimulation (vns) second-line treatment treatment-resistant major depressive disorder (trd),"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output correctly identifies VNS as a treatment for major depressive disorder, but it does not mention the other somatic treatments included in the ground truth.",0.75
cognitive behavioral therapy (cbt) treats major depressive disorder,Group therapy Reduces Depressive Symptoms,"Score: 0.75
Explanation: The LLM output is related to therapy for depressive disorder but specifies cognitive behavioral therapy (CBT) instead of group therapy, which reduces the overall correctness of the statement.",0.75
psychoeducation treats depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.50
The LLM output is not highly correct as it incorrectly states that psychoeducation treats depression, instead of pharmacotherapy.",0.5
"electroconvulsive therapy (ect) recommended for patients with severe and psychotic depression, high risk of suicide, parkinson’s disease, and pregnant patients","Electroconvulsive therapy Eligible for Patients with severe and psychotic depression, a high risk of suicide, or Parkinson’s disease, as well as pregnant patients","Score: 0.95
The LLM output is almost identical to the ground truth, with only minor differences in wording.",0.95
electroconvulsive therapy (ect) treats major depressive disorder (mdd),Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is mostly correct in identifying a treatment for major depressive disorder, but it incorrectly specifies electroconvulsive therapy instead of marital and family therapy for severe forms of depression associated with medications and hospitalization.",0.75
electroconvulsive therapy (ect) definition the most document and effective method in neuro-modulation treatment for depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies electroconvulsive therapy as a somatic therapy option for depression, but it oversimplifies its effectiveness compared to other treatment options mentioned in the ground truth.",0.75
repetitive transcranial magnetic stimulation (rtms) treats major depressive disorder (mdd),Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.80
The LLM output is quite accurate as it highlights the use of repetitive transcranial magnetic stimulation in treating major depressive disorder, although it misses out on mentioning the comparison with antidepressants.",0.8
"mirtazapine more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Mirtazapine As effective as SSRIs,"Score: 0.70
The LLM output includes additional information about the effectiveness of mirtazapine compared to other SSRIs, but it is not directly comparing its effectiveness to SSRIs as stated in the Ground Truth.",0.7
"escitalopram more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies escitalopram as being more effective than other antidepressants, but inaccurately includes reboxetine as more effective.",0.75
electroconvulsive therapy (ect) associated with reduction in psychiatric readmissions,Electroconvulsive therapy Reduces Number of hospital readmissions,"Score: 0.85
The LLM output is mostly correct by capturing the main idea of the ground truth, but it includes a slight error with ""psychiatric"" instead of ""hospital"" readmissions.",0.85
"venlafaxine more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies multiple antidepressants but does not mention repetitive Transcranial Magnetic Stimulation (rTMS) as being more effective.",0.75
"sertraline more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output correctly identifies sertraline as one of the SSRIs mentioned in the ground truth statement, but includes additional medications not listed in the ground truth.",0.75
ketamine associated with risk of misuse and abuse,"Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 0.75
The LLM output correctly states that ketamine is associated with the risk of misuse and abuse, but it does not address the comprehensive list of side effects associated with the drug.",0.75
electroconvulsive therapy (ect) side effects cognitive side effects,"Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 0.50
The LLM output is partially incorrect as it mentions ""cognitive side effects"" but does not address the other side effects of ketamine listed in the ground truth.",0.5
reboxetine less effective all tested antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.25
The LLM output contradicts the ground truth statement by stating that reboxetine is less effective, when the ground truth indicates that rTMS and antidepressants are more effective.",0.25
"venlafaxine more effective fluoxetine, fluvoxamine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM output correctly identifies venlafaxine as more effective than fluoxetine and fluvoxamine, but does not mention repetitive Transcranial magnetic stimulation as being more effective than antidepressants in general.",0.5
major depressive disorder (mdd) definition a mood disorder causing a persistent feeling of sadness and loss of interest,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is relevant to depression but does not directly address the effectiveness of marital and family therapy for treating severe forms associated with medications and hospitalization.",0.75
"escitalopram more effective citalopram, reboxetine, paroxetine, fluoxetine, fluvoxamine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.50
The LLM output incorrectly compared the effectiveness of different SSRIs, but did include some correct drugs in the list.",0.5
reboxetine less effective all the other 11 antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output is only partially correct as it incorrectly states that reboxetine is less effective than all other 11 antidepressants, while the ground truth statement focuses on the effectiveness of rTMS compared to antidepressants in general.",0.75
escitalopram comparable to sertraline,Nefazodone Is comparable to SSRI,"Score: 0.50
The overall correctness score is lower as the LLM output does not directly match the ground truth statement.",0.5
"mirtazapine more effective fluoxetine, venlafaxine",Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output is mostly correct as it states that mirtazapine is more effective than fluoxetine and venlafaxine, which are both SSRIs, in treating depression, although it doesn't directly compare mirtazapine to all SSRIs as in the ground truth statement.",0.75
sertraline highly effective major depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.50

The LLM output is not entirely correct as it focuses on sertraline for major depression instead of electroconvulsive therapy for acute phase of depression, but it does mention effectiveness in treating depression.",0.5
escitalopram highly effective major depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.50
The LLM output is partially correct as it mentions a specific drug for treating major depression, but it is not as accurate or comprehensive as the ground truth statement which includes information about electroconvulsive therapy being effective for acute phase depression in some cases.",0.5
venlafaxine highly effective major depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.50
The LLM output only partially captures the main idea of the ground truth, as it mentions a specific medication rather than electroconvulsive therapy and does not specify the context of the acute phase of depression.",0.5
reboxetine not effective major depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is mostly incorrect as it states that reboxetine is not effective for major depression, which is not entirely accurate, but it does correctly imply that electroconvulsive therapy can be effective for acute phase depression.",0.75
sertraline comparable to escitalopram,Nefazodone Is comparable to SSRI,"Score: 0.50
The LLM output is partially correct as it mentions two SSRIs, but it does not specifically mention Nefazodone which is the ground truth comparison drug.",0.5
mirtazapine highly effective major depression,Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output is mostly accurate, but it fails to directly compare Mirtazapine to SSRIs as the ground truth statement does.",0.75
"sertraline more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies sertraline as one of the more effective antidepressants, but does not mention rTMS as being more effective overall.",0.75
"escitalopram more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.50
The LLM output is partially correct as it correctly identifies escitalopram as one of the SSRIs mentioned in the ground truth but includes other drugs that are not SSRIs in its comparison.",0.5
"venlafaxine more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies venlafaxine as more effective than other antidepressants, but misses the mention of repetitive Transcranial magnetic stimulation (rTMS) being more effective overall.",0.75
"bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, venlafaxine treats unipolar major depression in adults",Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct in listing various pharmacotherapies for treating unipolar major depression in adults, but it includes some medications not typically used for the acute phase of depression.",0.75
escitalopram benefits balance between efficacy and acceptability,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.50
The LLM output does not accurately reflect the ground truth statement about Deep Brain Stimulation findings in depression patients, as it focuses on escitalopram benefits instead.",0.5
repetitive transcranial magnetic stimulation (rtms) comparable to electroconvulsive therapy (ect),"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies repetitive transcranial magnetic stimulation (rTMS) as a somatic therapy option comparable to electroconvulsive therapy (ECT), but does not mention other acute-phase treatment options for depression.",0.75
exercise benefits improvement in symptom severity and quality of life in severe mdd,Physical Exercise Benefits Improvements in one’s quality of life,"Score: 0.75
The LLM output accurately captures the main idea of the ground truth but focuses specifically on the benefits for individuals with severe Major Depressive Disorder.",0.75
selective serotonin reuptake inhibitors (ssri) associated with increased risk of sexual dysfunction,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.75
The LLM output is partially correct, as it mentions a type of antidepressant medication (SSRIs) but does not align with the ground truth statement about norepinephrine reuptake inhibitors.",0.75
sertraline recommended starting treatment for moderate to severe unipolar major depression in adults,Depression Side effect Slower response to treatment,"Score: 0.50
The LLM output does not directly address the concept of slower response to treatment in depression, although it does mention a recommended treatment for depression.",0.5
venlafaxine comparable to selective serotonin reuptake inhibitors (ssri) and other antidepressants,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.75
The LLM output is mostly correct as it correctly identifies venlafaxine as a serotonin and norepinephrine reuptake inhibitor, but it states that it is comparable to SSRIs instead of focusing specifically on norepinephrine reuptake inhibitors.",0.75
anxious depression associated with poor acute outcome following antidepressant treatment,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output captures the overall idea of the ground truth statement, but adds the element of anxiety and specifies a poor acute outcome following antidepressant treatment instead of just a slower response to treatment.",0.75
anxious depression more common than nonanxious depression,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output is not directly related to the ground truth statement and therefore receives a lower score.",0.5
"all depression definition a mental health disorder characterized by persistently depressed mood or loss of interest in activities, causing significant impairment in daily life",Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct in defining depression as a mental health disorder, but does not specifically mention pharmacotherapy treating the acute phase of depression.",0.75
bupropion benefits patients with depression requiring an antidepressant with fewer sexual side effects,Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output partially addresses the ground truth statement by discussing the benefits of bupropion for depression but does not specifically mention suicidal behavior as a side effect.",0.75
citalopram first-line treatment level 1 of star*d for major depressive disorder,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is partially correct as it mentions a specific medication (citalopram) as a first-line treatment for major depressive disorder, but does not accurately match the ground truth statement about depression-focused psychotherapy being the second most common treatment for acute phase depression.",0.75
anxious depression definition major depressive disorder with high levels of anxiety symptoms,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is somewhat relevant to the ground truth in terms of discussing symptoms of depression, but it does not accurately reflect the focus on treatment and specific phase mentioned in the ground truth.",0.75
anxious depression more common than nonanxious depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.50
The LLM output is partially correct in stating that anxious depression may be more common than nonanxious depression, but it does not accurately reflect the ground truth statement about depression-focused psychotherapy being the second most common treatment for acute phase depression.",0.5
nonanxious depression definition major depressive disorder without high levels of anxiety symptoms,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.75
The LLM output is partially correct as it does mention depression, but it does not accurately describe problem-solving therapy or its use in preventing depression among the elderly and treating patients with mild depressive symptoms.",0.75
anxious depression associated with more medical comorbidity,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output is not correct as it does not accurately reflect the information provided in the ground truth statement about the properties of bupropion compared to SSRIs.",0.5
anxious depression results lower remission rates,Transcranial direct current stimulation Results Outperforms the simulator by rate of response and remission,"Score: 0.75
The LLM output is partially correct, as it mentions lower remission rates, but it does not accurately reflect the comparison to transcranial direct current stimulation results.",0.75
citalopram treats major depressive disorder,Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.25
The LLM output is not correct as it is discussing the treatment of major depressive disorder with citalopram, rather than schema therapy for patients with personality disorder comorbidity, resulting in a low overall correctness score.",0.25
electroconvulsive therapy (ect) overview usage in the treatment of major depressive disorder and its potential mechanism,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct in terms of discussing a treatment for depression, but it focuses on electroconvulsive therapy (ECT) instead of depression-focused psychotherapy, making it partially correct.",0.75
anxious depression symptom increased risk of suicidality,Pharmacotherapy Treats Acute phase of depression,"Score: 0.50
The LLM output partially addresses the topic of depression but does not directly compare to the ground truth statement, resulting in a lower correctness score.",0.5
anxious depression associated with serious adverse psychiatric events,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.50
The LLM output is partially correct as it mentions depression, but it inaccurately describes it as anxious and associates it with serious adverse psychiatric events instead of medications and hospitalization.",0.5
sustain-release bupropion second-line treatment nonremitters to citalopram in level 2 of star*d,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75

The LLM output is partially correct as it mentions a specific medication (bupropion) for treatment-resistant depression, but it does not encompass all the acute-phase treatment options as stated in the Ground Truth.",0.75
anxious depression associated with greater overall number of comorbid axis i condition,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.50
The LLM output is partially correct as it mentions comorbid conditions, but it does not accurately reflect the treatment of severe forms of depression with marital and family therapy.",0.5
anxious depression associated with greater likelihood of reported suicidal ideation,Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output is mostly correct but includes ""anxious"" which was not present in the ground truth statement.",0.75
citalopram treats anxious depression symptoms,Pharmacotherapy Treats Acute phase of depression,"Score: 0.70

The LLM output is partially correct as it mentions citalopram, a medication commonly used to treat depression, but it inaccurately specifies that it treats ""anxious depression symptoms"" instead of the acute phase of depression.",0.7
anxious depression associated with specific treatment responsivity,Depression Side effect Slower response to treatment,"Score: 0.50
The LLM output does capture the idea of depression and treatment response, but it also introduces the term ""anxious"" which was not present in the ground truth statement.",0.5
anxious depression associated with poorer treatment outcome with antidepressant monotherapy,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output captures the general idea of the ground truth statement but adds some details about specific type of depression and treatment outcome.",0.75
serotonin and noradrenaline reuptake inhibitors (snri) definition a class of medication used in the treatment of major depressive disorder that inhibits the reuptake of serotonin and noradrenaline,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.85
The LLM output provides a detailed and accurate definition of serotonin and noradrenaline reuptake inhibitors (SNRIs), but it does not directly address the comparison with depression-focused psychotherapy as stated in the ground truth.",0.85
"anxious depression associated with higher side effect frequency, intensity, and burden",Depression Side effect Suicidal behavior,"Score: 0.60
The LLM output captures elements of the ground truth by mentioning depression and side effects, but does not directly mention suicidal behavior.",0.6
"second-generation antidepressants definition a category of medications for major depressive disorder that includes both selective serotonin reuptake inhibitors (ssris) and serotonin and noradrenaline reuptake inhibitors (snris) among others, known for their improved side effect profile over first-generation antidepressants",SSRIs Is a part of Pharmacotherapy,"Score: 0.80
The LLM output provides a more detailed and accurate explanation of SSRIs as a category of medications within pharmacotherapy for major depressive disorder, but could be improved by explicitly stating that SSRIs are a part of pharmacotherapy.",0.8
anxious depression less effective antidepressant treatment in achieving remission compared to nonanxious depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct in capturing the essence of the ground truth, but introduces the term 'anxious depression' which may not be explicitly mentioned in the ground truth statement.",0.75
anxious depression definition a subtype of major depressive disorder with prominent anxiety features,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.75

The LLM output is mostly incorrect as it describes a subtype of major depressive disorder rather than cognitive-behavioral therapy for depressed patients with irrational beliefs, but it does mention anxiety features, which are relevant to depression.",0.75
"anxious depression side effects greater frequency, intensity, and burden of side effects",Depression Side effect Slower response to treatment,"Score: 0.80
The LLM output captures the essence of the ground truth statement but adds additional details that are not explicitly mentioned, which may slightly lower its overall correctness score.",0.8
anxious depression associated with shorter time in treatment and on the final citalopram dosage,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output does not accurately reflect the ground truth statement, as it talks about citalopram dosage and treatment time instead of the effects of Ketamine on different types of depression.",0.75
